Nasdaq Notice Regarding

Related by string. NASDAQ Notice Regarding * NASDAQ. . nasdaq . NASDAQ : Inc. NASDAQ SCOR . NASDAQ OMX Group . Nasdaq Listing Qualifications . Apple Nasdaq AAPL / NOTICES . Notices . NOTICE : NOTICE IS HEREBY GIVEN . Legal Notice Regarding . NOTICE TEXT Department / regards . regarding . Regarded : Cautionary Note Regarding Forward . Caution Regarding Forward Looking . highly regarded * *

Related by context. Frequent words. (Click for all words.) 76 Regains Compliance With 76 Regains Compliance 75 Annual Meeting Date 74 FY# Guidance 73 Updates Guidance 72 Option Grants 72 Forecast Quick Facts 71 Q1 Loss Narrows 71 Q2 Loss Narrows 71 Universal Shelf Registration 71 Q3 Loss Narrows 71 Continued Listing 71 Reaffirms Guidance 71 Cent Dividend 71 Guidance Quick Facts 71 Share Repurchases 70 Shelf Registration 70 Files Shelf Registration Statement 70 Record Second Quarter 70 Increases Quarterly Cash Dividend 70 Record Third Quarter 70 Files Annual Report 70 Fourth Quarter Dividend 70 Share Buyback Program 69 Extends Tender Offer 69 Lowers Guidance 69 #.#/Share [002] 69 CFO Resigns 69 Q1 Loss Widens 69 Guides FY# Quick Facts 69 Completes Tender Offer 69 Guides Q3 69 Vertex Pharmaceuticals Announces 69 Patient Enrollment 69 Explore Strategic Alternatives 69 Q2 Loss Widens 69 Guides Q4 69 Stockholders Approve Merger 69 Previously Announced 69 Fourth Consecutive Year 69 美 通 社 68 Announces Stockholder Approval 68 Opns 68 Guides Q2 68 Q4 Loss Narrows 68 Provides Guidance 68 Above Consensus 68 Monthly Dividends 68 Lifts FY# EPS 68 Bullish Engulfing Pattern 68 Sixth Consecutive Year 68 PLEASE REFER TO 68 Revenues Decline 68 Preliminary Third Quarter 68 View Quick Facts 68 Shelf Registration Statement 68 Stock Buyback 68 Bovie Medical Corporation 68 MITTEILUNG UEBERMITTELT VON BUSINESS 67 Dividend Increase 67 Completes Financing 67 Q2 Profit Surges 67 Shareholder Approval 67 Detects Unusual Activity 67 Record Fourth Quarter 67 Q3 Loss Widens 67 Shareholder Lawsuit 67 Pomerantz Law Firm 67 #/Share 67 Schedules Fiscal 67 Guides FY# 67 Director Shareholding 67 Revenue Grows 67 Shareholder Letter 67 .# Per Share 67 Q3 Profit Surges 67 Q4 Loss Widens 67 Declares Increased 67 Cyclacel Pharmaceuticals 67 Announces Share Repurchase 67 2nd Quarter Results 67 Statutory Basis 67 Calls Purchased 66 Declares Distribution 66 Amends Credit 66 Raises Quarterly Dividend 66 Common Share Dividend 66 1st Quarter Results 66 Q4 Profit Surges 66 Private Placement Financing 66 Million Revolving Credit 66 Review Initiated 66 3rd Quarter Results 66 Mln Common 66 Q1 Profit Surges 66 Boosts Dividend 66 Complete Merger 66 Million Stock Repurchase 66 Secures Financing 66 Stock Soars 66 Commence Trading

Back to home page